Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1179-1934
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Pharmacokinetic Profile of a 2-Month Dose Regimen of Aripiprazole Lauroxil: A Phase I Study and a Population Pharmacokinetic Model ; volume:31 ; number:7 ; day:8 ; month:6 ; year:2017 ; pages:617-624 ; date:7.2017
CNS drugs ; 31, Heft 7 (8.6.2017), 617-624, 7.2017
- Classification
-
Medizin, Gesundheit
- Creator
-
Hard, Marjie L.
- Contributor
-
Mills, Richard J.
Sadler, Brian M.
Wehr, Angela Y.
Weiden, Peter J.
Moltke, Lisa von
SpringerLink (Online service)
- DOI
-
10.1007/s40263-017-0447-7
- URN
-
urn:nbn:de:1111-201708035464
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:56 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Hard, Marjie L.
- Mills, Richard J.
- Sadler, Brian M.
- Wehr, Angela Y.
- Weiden, Peter J.
- Moltke, Lisa von
- SpringerLink (Online service)
Other Objects (12)
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling
Clinical Pharmacokinetic Studies of Enzalutamide
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Acenocoumarol’s pharmacokinetic : linear or not?
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling
Clinical Pharmacokinetic Studies of Enzalutamide
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria
Acenocoumarol’s pharmacokinetic : linear or not?
A Two-Dose Oritavancin Regimen Using Pharmacokinetic Estimation Analysis
Population Pharmacokinetic Analysis and Model-Based Simulations of Aripiprazole for a 1-Day Initiation Regimen for the Long-Acting Antipsychotic Aripiprazole Lauroxil
Influence of CYP2D6 Phenotypes on the Pharmacokinetics of Aripiprazole and Dehydro-Aripiprazole Using a Physiologically Based Pharmacokinetic Approach
Pharmacokinetic Evaluation of Intravenous Vitamin C: A Classic Pharmacokinetic Study
Entrectinib dose confirmation in pediatric oncology patients: pharmacokinetic considerations
A minimal physiologically based pharmacokinetic model for high-dose methotrexate
Pooled Population Pharmacokinetic Analysis for Exploring Ciprofloxacin Pharmacokinetic Variability in Intensive Care Patients
Time Scale Calculus: a new approach to multi-dose pharmacokinetic modeling
Clinical Pharmacokinetic Studies of Enzalutamide
Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients
Population Pharmacokinetic and Pharmacokinetic/Pharmacodynamic Analyses of Pegcetacoplan in Patients with Paroxysmal Nocturnal Hemoglobinuria